International law, public health, and the meanings of pharmaceuticalization.
International law, public health, and the meanings of pharmaceuticalization.
复制标题
DOI：
10.1080/14636778.2014.951994
复制
发表时间：
2014-10-02
影响因子：
1.8
通讯作者：
Pickersgill M
中科院分区：
文献类型：
--
作者：
Cloatre E;Pickersgill M
最近的社会科学奖学金在分析药物的生产、流通和使用时使用了“药物化”一词。在本文中，我们试图通过考虑法律和法律的程序在指导药品流动中的作用，进一步讨论其作为分析设备的范围、限制和潜力。为此，我们综合了一系列与获取药品和知识产权法之间的关系有关的经验和概念性工作。本文建议，除了记录特定药物需求的扩大或减少，分析师的药物化出席的方式，其中社会法律的发展变化（或不）的身份的药物，并通过其流通的手段，并来使用的国家和公民。这种学术研究有可能更精确地定位塑造国际议程和目标、形成市场和产生健康的生物政治过程。
Recent social science scholarship has employed the term “pharmaceuticalization” in analyses of the production, circulation and use of drugs. In this paper, we seek to open up further discussion of the scope, limits and potential of this as an analytical device through consideration of the role of law and legal processes in directing pharmaceutical flows. To do so, we synthesize a range of empirical and conceptual work concerned with the relationships between access to medicines and intellectual property law. This paper suggests that alongside documenting the expansion or reduction in demand for particular drugs, analysts of pharmaceuticalization attend to the ways in which socio-legal developments change (or not) the identities of drugs, and the means through which they circulate and come to be used by states and citizens. Such scholarship has the potential to more precisely locate the biopolitical processes that shape international agendas and targets, form markets, and produce health.
登录
查看更多内容
影响因子：
3.6
作者：
Coveney, Catherine;Gabe, Jonathan;Williams, Simon
通讯作者：
Williams, Simon
DOI：
10.1177/0038038510369368
发表时间：
2010-08-01
影响因子：
2.9
作者：
Abraham, John
通讯作者：
Abraham, John
影响因子：
1
作者：
Carpenter, Daniel;Tobbell, Dominique A.
通讯作者：
Tobbell, Dominique A.
影响因子：
2.2
作者：
Hayden, Cori
通讯作者：
Hayden, Cori
影响因子：
9.7
作者：
Attaran, A
通讯作者：
Attaran, A